Israel - hebreo - Ministry of Health

comex ltd - carprofen 50 mg - tablets - for analgesia and reduction of chronic inflammation, for example in degenerative joint disease, in dogs.

Israel - hebreo - Ministry of Health

comex ltd - carprofen 20 mg - tablets - for analgesia and reduction of chronic inflammation, for example in degenerative joint disease, in dogs.

Israel - hebreo - Ministry of Health

zoetis israel holding b.v., israel - carprofen - טבליה - carprofen 100 mg

Israel - hebreo - Ministry of Health

zoetis israel holding b.v., israel - carprofen - טבליה - carprofen 20 mg

Israel - hebreo - Ministry of Health

zoetis israel holding b.v., israel - carprofen - טבליה - carprofen 50 mg

Israel - hebreo - Ministry of Health

comex ltd - carprofen - טבליה - carprofen 20 mg

Israel - hebreo - Ministry of Health

comex ltd - carprofen - טבליה - carprofen 50 mg

Israel - hebreo - Ministry of Health

zoetis israel holding b.v., israel - carprofen - טבליה - carprofen 50 mg

Israel - hebreo - Ministry of Health

comex ltd - carprofen - תמיסה להזרקה - carprofen 50 mg/ml - in dogs : for the control of post-operative pain and inflammation following orthopaedic and soft tissue (including intra-ocular) surgery. in cats: for the treatment of post-operative pain following surgery.

Israel - hebreo - Ministry of Health

novartis israel ltd - omalizumab - אבקה וממס להכנת תמיסה להזרקה - omalizumab 150 mg/dose - omalizumab - omalizumab - xolair is indicated for adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. xolair has been shown to decrease the incidence of asthma exacerbations in these patients. safety and efficacy have not been established in other allergic conditions.